Moreover, considering the role of inflammation in the pathogenesis of stroke [32,33] as well as, potentially, in the HT following delayed tPA treatment [34], it would be worthwhile to examine whether G-CSF alters the expression of inflammatory markers or of their modulators to reduce delayed tPA-induced outcomes, especially, HT. Here, CSF3 is linked to hematocrit.